NewsRx

Search our medical news database

Clinical Data, Inc.

Clinical Data Prices 3,000,000 Share Common Stock Offering

Published in Medicine and Law Weekly, August 3rd, 2007

Clinical Data, Inc. (NASDAQ: CLDA) announced the pricing of an underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $22.00 per share. All of the shares are being offered by Clinical Data pursuant to an effective shelf registration statement previously filed with the Securities and Exchange Commission. Bear, Stearns & Co. Inc. is acting as sole book-running manager of the offering and Lazard Capital Markets LLC is acting as co-manager. In connection with this offering, Clinical Data granted the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock at the public offering price to cover over-allotments, if...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook